⌘K

Home/Filings/4/0000912282-25-000697

4//SEC Filing

Hannah Brendan 4

Accession 0000912282-25-000697

CIK 0001662774other

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 8:48 AM ET

Size

6.4 KB

Accession

0000912282-25-000697

Insider Transaction Report

Form 4

Period: 2025-06-18

Quince Therapeutics, Inc.QNCX

CBO, COO and CCO

Transactions

Award
Common Shares
2025-06-18$1.20/sh+37,736$45,283→ 334,276 total
Award
Warrants
2025-06-18$0.13/sh+37,736$4,717→ 37,736 total
Exercise: $1.20From: 2025-06-18Exp: 2030-06-18→ Common Shares (37,736 underlying)

Documents

1 file

4
form4.xmlPrimary

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1

filerCIK 0001929422

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 8:48 AM ET
Size: 6.4 KB

View on SEC.gov